Literature DB >> 10444227

Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects.

I Hindmarch1, Z Shamsi.   

Abstract

Behavioural changes are produced by any drug that enters the central nervous system. These psychoactive effects include changes in alertness, concentration, attention, memory, cognition, psychomotor accuracy, skilled performance and affect. Changes in psychological performance may affect the safety of both the individuals taking the drug and of those people coming into contact with them. The aims of psychopharmacological performance tests are to describe the nature, extent and severity of these changes and identify drugs without deleterious effects upon performance. Use of traditional antihistamines has until recently been associated with a number of undesirable side-effects, the most troublesome of which is sedation. There are two aspects to sedation. Firstly, an objectively determined one based on the results of psychometric tests from controlled trials and secondly, the subjects response to the administration of a drug. Although the second generation of antihistamines have a much more favourable therapeutic index, use of these agents has also been reported to cause varying degrees of sedation. As antihistamines are largely used by ambulant patients, a complete evaluation of sedation should be performed through standardized objective tests, shown to be sensitive to the central effects of antihistamines as well as reliable ratings of subjective experiences. An extensive review of the literature has identified a number of tests which appear to be sensitive to the central effects of antihistamines. These include tests of psychomotor performance, sensori-motor co-ordination speed, information processing, sensory skills as well as physiological measures and subjective rating scales. Using this battery of cognitive and psychomotor tests, it is evident that only a very limited number of antihistamines can claim to be virtually free of both objective and subjective sedative effects, although the second generation of antihistamines are generally less impairing than the original ones; when prescribed at their recommended doses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10444227     DOI: 10.1046/j.1365-2222.1999.0290s3133.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  24 in total

Review 1.  Sedation, cognition, and antihistamines.

Authors:  Julie C Qidwai; Ginger S Watson; John M Weiler
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

Review 2.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.

Authors:  Eef L Theunissen; Annemiek Vermeeren; Johannes G Ramaekers
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

4.  Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.

Authors:  K Simpson; B Jarvis
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

5.  Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target.

Authors:  Fabio Broccatelli; Emanuele Carosati; Gabriele Cruciani; Tudor I Oprea
Journal:  Mol Inform       Date:  2010-01-12       Impact factor: 3.353

Review 6.  Selecting the optimal oral antihistamine for patients with allergic rhinitis.

Authors:  Jeffrey M Lehman; Michael S Blaiss
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers.

Authors:  J M Gandon; H Allain
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

8.  Effects of sedative and nonsedative antihistamines on prefrontal activity during verbal fluency task in young children: a near-infrared spectroscopy (NIRS) study.

Authors:  Takeo Tsujii; Sayako Masuda; Eriko Yamamoto; Takayuki Ohira; Takekazu Akiyama; Takao Takahashi; Shigeru Watanabe
Journal:  Psychopharmacology (Berl)       Date:  2009-08-25       Impact factor: 4.530

9.  Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance.

Authors:  P van Ruitenbeek; A Vermeeren; F T Y Smulders; A Sambeth; W J Riedel
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

10.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.